HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.
作者信息
Rajan V S, Sng E H, Pang R, Tan N J, Thirumoorthy T, Yeo K L
出版信息
Br J Vener Dis. 1980 Aug;56(4):255-8. doi: 10.1136/sti.56.4.255.
Abstract
HR 756, a new cephalosporin, was used in single intramuscular doses of 500 mg to treat 108 men and women with gonorrhoea caused by penicillinase-producing Neisseria gonorrhoeae (PPNG) and non-PPNG. Of 102 patients followed up, 99 (97.05%) were cured. Cure rates for PPNG infections and non-PPNG infections were 98.18% and 95.74% respectively. Few adverse side effects were recorded but possible cross-sensitisation with penicillin was observed. Clinical and laboratory antibiotic susceptibility results correlated well. It is concluded that this drug is safe and effective in treating both PPNG and non-PPNG infectons.
摘要
相似文献
1
HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.
Br J Vener Dis. 1980 Aug;56(4):255-8. doi: 10.1136/sti.56.4.255.
2
Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Genitourin Med. 1986 Aug;62(4):224-7. doi: 10.1136/sti.62.4.224.
3
Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.
Br J Vener Dis. 1982 Oct;58(5):314-6. doi: 10.1136/sti.58.5.314.
4
Cefuroxime, thiamphenicol, spectinomycin, and penicillin G in uncomplicated infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
Br J Vener Dis. 1983 Jun;59(3):172-5. doi: 10.1136/sti.59.3.172.
5
A decade of PPNG in Singapore.
Ann Acad Med Singap. 1987 Oct;16(4):639-44.
6
Cefotaxime in the treatment of gonorrhoea caused by penicillinase producing N. gonorrhoeae (PPNG) and non penicillinase producing N. gonorrhoeae (Non PPNG).
J Med Assoc Thai. 1982 May;65(5):271-6.
7
[Ceftriaxone as a single-dose treatment for male gonococcal urethritis].
Jpn J Antibiot. 1984 Nov;37(11):2169-73.
8
Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.
Genitourin Med. 1985 Apr;61(2):106-8. doi: 10.1136/sti.61.2.106.
9
Antimicrobial sensitivity of Neisseria gonorrhoeae. Comparison of penicillinase producing and non-penicillinase producing strains.
Br J Vener Dis. 1983 Oct;59(5):289-92. doi: 10.1136/sti.59.5.289.
10
Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
Antimicrob Agents Chemother. 1996 Dec;40(12):2775-80. doi: 10.1128/AAC.40.12.2775.
引用本文的文献
1
Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.
Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):337-40. doi: 10.1136/bmj.285.6338.337.
2
Penicillinase-producing Neisseria gonorrhoeae in Riyadh, Saudi Arabia.
Br J Vener Dis. 1981 Aug;57(4):256-8. doi: 10.1136/sti.57.4.256.
3
Gentamicin in the treatment of infections due to penicillinase-producing gonococci.
Br J Vener Dis. 1980 Dec;56(6):394-6. doi: 10.1136/sti.56.6.394.
4
Gonorrhoea: a continuing problem in the 1980s.
Br J Vener Dis. 1980 Aug;56(4):193. doi: 10.1136/sti.56.4.193.
5
Two dose Augmentin treatment of acute gonorrhoea in men.
Br J Vener Dis. 1984 Jun;60(3):161-3. doi: 10.1136/sti.60.3.161.
6
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Drugs. 1983 Mar;25(3):223-89. doi: 10.2165/00003495-198325030-00001.
7
Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.
Arch Dermatol Res. 1982;274(3-4):321-6. doi: 10.1007/BF00403736.
8
Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.
Br J Vener Dis. 1982 Oct;58(5):314-6. doi: 10.1136/sti.58.5.314.
9
Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime.
Br J Vener Dis. 1981 Jun;57(3):162-4. doi: 10.1136/sti.57.3.162.
10
Rosoxacin in the treatment of uncomplicated gonorrhoea in men.
Br J Vener Dis. 1984 Aug;60(4):231-4. doi: 10.1136/sti.60.4.231.
本文引用的文献
1
Single-dose treatment of gonorrhea with selected antibiotic agents.
JAMA. 1969 Nov 3;210(5):857-61.
2
Treatment of gonorrhoea contracted in the Western Pacific Region.
Br J Vener Dis. 1974 Apr;50(2):113-6. doi: 10.1136/sti.50.2.113.
3
New system for cultivation of Neisseria gonorrhoeae.
Appl Microbiol. 1974 Apr;27(4):802-5. doi: 10.1128/am.27.4.802-805.1974.
4
Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance.
Antimicrob Agents Chemother. 1975 Mar;7(3):265-70. doi: 10.1128/AAC.7.3.265.
5
Clinical experience in the use of cefuroxime in gonorrhoea.
Br J Vener Dis. 1978 Dec;54(6):400-2. doi: 10.1136/sti.54.6.400.
6
The efficacy of cefuroxime for the treatment of acute gonorrhoea in men.
Br J Vener Dis. 1978 Jun;54(3):165-7. doi: 10.1136/sti.54.3.165.
7
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
Antimicrob Agents Chemother. 1979 Feb;15(2):273-81. doi: 10.1128/AAC.15.2.273.
8
Epidemiology and treatment of gonorrhoea caused by penicillinase-producing strains in Liverpool.
Br J Vener Dis. 1978 Feb;54(1):28-35. doi: 10.1136/sti.54.1.28.
9
HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.
Antimicrob Agents Chemother. 1978 Dec;14(6):807-11. doi: 10.1128/AAC.14.6.807.
10
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae.
Antimicrob Agents Chemother. 1979 Mar;15(3):452-4. doi: 10.1128/AAC.15.3.452.
Zotero 插件